Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Industry Size (2026) USD 2.9 Bn Forecast (2036) USD 11.1 Bn CAGR (2026 to 2036) 14.90% GLP-1 Obesity Home Delivery Injectables Market Forecast and Outlook 2026 to 2036 The GLP-1 obesity home delivery injectables market is likely to reach USD 2.9 billion in 2026 and is projected to reach USD 11.1 billion by 2036, expanding at a CAGR of 14.90% over the forecast period
Freezing causes immediate, mechanical damage through ice crystal formation that physically ruptures peptide structures
They found that people taking GLP-1 medications had a 37% increased relative risk of gallbladder problems compared to those not taking the medication
Community sources describe freeze-thaw cycles producing visible particulates in some cases typically traced to crystallization or container-integrity issues
US$ 26.98
US$ 25.61
US$ 22.99
US$ 24.24
US$ 29.11
